Amy Wagers: Repairing Genes That Cause Muscular Dystrophy - United For Medical Research
UMR releases new fact sheets on COVID-19 and biomedical research. Read here
See how UMR members are aiding in the fight against the coronavirus here
NIH's Role in Sustaining the U.S. Economy 2020 Update Now Available Here 
A new episode of the Amazing Things Podcast is now available! Check it out here.
UMR Thanks Appropriations, Congressional Leaders for Strong FY20 NIH Funding. View statement here

A participant in the NIH 2019-2020 Medical Research Scholars Program.

Photo Credit: National Institutes of Health

About This Photo

Amy Wagers: Repairing Genes That Cause Muscular Dystrophy

Summary

Thousands of diseases are rooted in our genes, occurring when something goes wrong during cell multiplication and causes a mutation in the gene’s DNA sequence. This is why researchers the world over heralded the 2012 revelation of the CRISPR-Cas9 system, a groundbreaking tool for editing faulty genes. CRISPR-Cas9 allows scientists with relative ease and precision to snip out a segment of mutated or damaged DNA, correcting genes that are disease-causing and opening the door to potential treatments for diseases where there currently are none. Duchenne muscular dystrophy (DMD) is one of those diseases, and Dr. Amy Wagers of the Harvard Stem Cell Institute is leading an effort to use edited stem cells to treat Duchenne.